Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Cutaneous Drug Eruptions (eBook)

Diagnosis, Histopathology and Therapy
eBook Download: PDF
2015 | 1st ed. 2015
XXI, 463 Seiten
Springer London (Verlag)
978-1-4471-6729-7 (ISBN)

Lese- und Medienproben

Cutaneous Drug Eruptions -
Systemvoraussetzungen
106,99 inkl. MwSt
(CHF 104,50)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
​The burden of cutaneous drug reactions is significant, in both outpatient and inpatient settings,  and can result in morbidity and even mortality.  This book is unique in its approach to this problem.  This text is divided into basic principles, common drug reactions, skin conditions mimicked by drug reactions, drug reactions to the skin appendages, life-threatening drug reactions, less common drug reactions, and special groupings of drug reactions. For the clinician, the skin can only morphologically react in to many limited ways. This is also true for the pathologist.  Combining these two forever linked specialties is a synergistic paradigm that greatly enhances diagnosis, and ultimately therapy, for these pernicious conditions. Drug reactions in the skin remain a common complication of therapy.  True incidences of drug reactions are not available.  For general discussion, the rule of 3% can be applied with reasonable assuredness.  Approximately 3% of all hospitalized patients develop an adverse cutaneous drug reaction.  Approximately 3% of these reactions are considered severe.  Outpatient data is even more obscure, but at least 3% of dermatology clinic outpatient visits are due to a drug reaction.  Cutaneous drug reactions compromise approximately 3% of all drug reactions. Even more challenging is the fact that the most vulnerable populations to drug reactions are increasing and include the elderly patients on prolonged drug therapy, and patients that use multiple drugs at the same time.

Dr. John C. Hall graduated from the University of Nebraska College of Medicine in 1972. He works in Kansas City, MO and specializes in Dermatology. Dr. Hall is affiliated with Saint Lukes Hospital Of Kansas City and Truman Medical Center Hospital Hill.

Brian Hall completed his pathology residency at the University of Utah followed by a dermatopathology fellowship under Clay J. Cockerell at UT Southwestern Medical School in the Department of Dermatology. He has co-edited six dermatology and pathology textbooks with his father, John C. Hall, a well-known dermatologist in the Kansas City area.


The burden of cutaneous drug reactions is significant, in both outpatient and inpatient settings, and can result in morbidity and even mortality. This book is unique in its approach to this problem. This text is divided into basic principles, common drug reactions, skin conditions mimicked by drug reactions, drug reactions to the skin appendages, life-threatening drug reactions, less common drug reactions, and special groupings of drug reactions. For the clinician, the skin can only morphologically react in to many limited ways. This is also true for the pathologist. Combining these two forever linked specialties is a synergistic paradigm that greatly enhances diagnosis, and ultimately therapy, for these pernicious conditions. Drug reactions in the skin remain a common complication of therapy. True incidences of drug reactions are not available. For general discussion, the rule of 3% can be applied with reasonable assuredness. Approximately 3% of all hospitalized patients develop an adverse cutaneous drug reaction. Approximately 3% of these reactions are considered severe. Outpatient data is even more obscure, but at least 3% of dermatology clinic outpatient visits are due to a drug reaction. Cutaneous drug reactions compromise approximately 3% of all drug reactions. Even more challenging is the fact that the most vulnerable populations to drug reactions are increasing and include the elderly patients on prolonged drug therapy, and patients that use multiple drugs at the same time.

Dr. John C. Hall graduated from the University of Nebraska College of Medicine in 1972. He works in Kansas City, MO and specializes in Dermatology. Dr. Hall is affiliated with Saint Lukes Hospital Of Kansas City and Truman Medical Center Hospital Hill.Brian Hall completed his pathology residency at the University of Utah followed by a dermatopathology fellowship under Clay J. Cockerell at UT Southwestern Medical School in the Department of Dermatology. He has co-edited six dermatology and pathology textbooks with his father, John C. Hall, a well-known dermatologist in the Kansas City area.

Immunology of Cutaneous Drug Eruptions.- Principles of Diagnosis of Cutaneous Drug Eruptions.- Histopathology of Drug Reactions.- Principles of Treatment of Cutaneous Drug Eruptions.- Morbilliform Drug Eruptions.- Drug-Induced Urticaria.- Erythema Multiforme and Drug Reactions.- Drug-Induced Vasculitis.- Pigment Changes and Drug Reactions.- Drug-induced Photosensitivity.- Erythema Nodosum as a Drug Eruption.- Lichen Planus Drug Reactions.- Pityriasis Rosea-Like Drug Eruptions.- Psoriasiform Drug Eruptions and Drugs that Flare Psoriasis.- Acne and Drug Reactions.- Collagen Vascular Diseases and Cutaneous Drug Reactions.- Fixed Drug Eruptions.- Autoimmune Bullous Diseases and Drugs.- Lymphoma and Pseudolymphoma and Drug Reactions.- Drug-Induced Alopecia.- Drug Eruptions of the Scalp.- Drug Reactions in the Nail in Cutaneous Drug Eruptions.- Drug Eruptions and Generalized Exfoliative Erythroderma.- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis.- Drug-induced Delayed Multi-organ Hypersensitivity Syndrome.- Acute Generalized Exanthematous Pustulosis.- Cutaneous Drug Reactions to Anticoagulants.- Antiepileptic Medications and Cutaneous Drug Reactions.- Chemotherapy and Cutaneous Drug Reactions.- Tyrosine Kinase Medications and the Skin.- Medical Therapies and Their effects on Skin Cancer.- Cutaneous Reactions to BRAF Inhibitors.- Cutaneous Reactions to Corticosteroids.- Cutaneous Reactions to Retinoids.- Neutrophilic Dermatoses.- Granulomatous Drug Reactions.- Cutaneous Drug Reactions in Patients Infected with Human Immunodeficiency Virus.- Pediatric Drug Eruptions of the Skin.

Erscheint lt. Verlag 21.8.2015
Zusatzinfo XXI, 463 p. 198 illus. in color.
Verlagsort London
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Dermatologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Studium Querschnittsbereiche Infektiologie / Immunologie
Schlagworte allergy • Dermatology Drugs • Drug reactions • drug safety • Skin Disease
ISBN-10 1-4471-6729-5 / 1447167295
ISBN-13 978-1-4471-6729-7 / 9781447167297
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 17,9 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich